Combi Corporation

Combi Co., Ltd.

Kyoto Prefectural Public University Corporation

Earthus, Inc.

Kyodoken Institute for Animal Science Research & Development

Kazunari Ushida

Takumi Watanabe

Takamitsu Tsukahara

Masaaki Okada

Hironari Koyama

Masaki Kuriyama

Ryo Inoue

Wakoto Bukawa

Tatsuhiko Kan

Noritaka Matsubara

The present invention provides a composition comprising a polymer of a &#x3b2;-hydroxy short-medium chain fatty acid, which is used for delivering the &#x3b2;-hydroxy short-medium chain fatty acid or an oligomer thereof to the large intestine. In case the composition is administrated orally, the composition will be delivered to the large intestine, without being degraded in the stomach or short intestine, and degraded by the large intestinal bacterial flora and release the short-medium chain fatty acid or an oligomer thereof. The released short-medium chain fatty acid or an oligomer thereof has useful physiological activities and is effective for treating or preventing inflammatory diseases or cancer in the large intestine.

Poly (&#x3b2;-hydroxy short-medium chain fatty acid)

A composition has an immunomodulation action, and comprises an RNA derived from a lactic acid bacterium as an effective component. Alternatively, a composition has a cytokine production-modulating action, and includes an RNA derived from a lactic acid bacterium as an effective component.

Composition comprising rna derived from lactic acid bacterium as effective component

The present invention is to provide a safe antidiarrheal agent and a method for suppressing diarrhea by which an efficient antidiarrheal effect is achieved without using antibiotics or synthetic antibacterial agents that have been conventionally used against infections in livestock and poultry. Antibiotic-resistant pathogenic infections can also be prevented and treated by the present invention. The antidiarrheal agent for livestock and poultry comprising heat-killed bacteria ofEC-12 (FERM ABP-10284) or a treated product thereof as an active ingredient is orally administered to livestock and poultry, particularly to breast-feeding sows and piglets around the weaning period.

Antidiarrheal agent for livestock and poultry

A composition comprisingstrain JCM1772 or strain iNP-001. The compositions may optionally contain live or processed bacterial products. A method for decreasing lactate production or increasing butyric acid production or for treating a disease associated with hyperlactate production in a non-ruminant using

Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same

Growing community of inventors

Nishinomiya, Japan

Kazunari Ushida